Citations

Mayo Clinic

Showing 10 of 108599 citations.

Feasibility, Benefits, and Limitations of a Penicillin Allergy Skin Testing Service
Narayanan, Prasanna P., Jeffres, Meghan N.

Annals of Pharmacotherapy | February 3, 2017 | Volume: 51 | Issue: 6 | Pages: 504-510

10.1177/1060028017690854 | PMID 28152605 Get It

Objective: To critically examine the feasibility, benefits, and limitations of an inpatient penicillin skin testing service and how pharmacists can be utilized. Data Sources: A PubMed search was performed from July 2016 through September 2016 using the following search terms: penicillin skin testing, penicillin allergy, β-lactam allergy. Additional references were identified from a review of literature citations. Study Selection and Data Extraction: All English-language studies assessing the use of penicillin skin testing as well as management and clinical outcomes of patients with a β-lactam allergy were evaluated. Data Synthesis: The prevalence of people self-identifying as penicillin allergic ranges from 10% to 20% in the United States. Being improperly labeled as penicillin allergic is associated with higher health care costs, worse clinical outcomes, and an increased prevalence of multidrug-resistant infections. Penicillin skin testing can be a tool used to clarify penicillin allergies and has been demonstrated to be a successful addition to antimicrobial stewardship programs in multiple health care settings. Prior to implementing a penicillin skin testing service, institutions will need to perform a feasibility analysis of who will supply labor and accept the financial burden as well as identify if the positive benefits of a penicillin skin testing service overcome the limitations of this diagnostic test. Conclusion: We conclude that institutions with high percentages of patients receiving non–β-lactams because of penicillin allergy labels would likely benefit the most from a penicillin skin testing service.
1571Risk factors for Tenofovir-associated Renal Dysfunction in HIV-positive Patients
Berg, Melody L. , Rizza, Stacey A. , Marcelin, Jasmine R , Cummins, Nathan W.

Open Forum Infectious Diseases | February 3, 2017 | Volume: 1 | Issue: suppl_1 | Pages: S418-S419

10.1093/ofid/ofu052.1117 Get It

Exertional dyspnea associated with chest wall strapping is reduced when external dead space substitutes for part of the exercise stimulus to ventilation
Garske, Luke , Lal, Ravin, Stewart, Ian B. , Morris, Norman , Cross, Troy J. , Adams, Lewis, Cross, Troy James

Journal of Applied Physiology | February 3, 2017 | Volume: 122 | Issue: 5 | Pages: 1179-1187

10.1152/japplphysiol.00051.2016 | PMID 28153938 Get It

Chest wall strapping has been used to assess mechanisms of dyspnea with restrictive lung disease. This study examined the hypothesis that dyspnea with restriction depends principally on the degree of reflex ventilatory stimulation. We compared dyspnea at the same (iso)ventilation when added dead space provided a component of the ventilatory stimulus during exercise. Eleven healthy men undertook a randomized controlled crossover trial that compared four constant work exercise conditions: 1) control (CTRL): unrestricted breathing at 90% gas exchange threshold (GET); 2) CTRL+dead space (DS): unrestricted breathing with 0.6-l dead space, at isoventilation to CTRL due to reduced exercise intensity; 3) CWS: chest wall strapping at 90% GET; and 4) CWS+DS: chest strapping with 0.6-l dead space, at isoventilation to CWS with reduced exercise intensity. Chest strapping reduced forced vital capacity by 30.4 ± 2.2% (mean ± SE). Dyspnea at isoventilation was unchanged with CTRL+DS compared with CTRL (1.93 ± 0.49 and 2.17 ± 0.43, 0–10 numeric rating scale, respectively; P = 0.244). Dyspnea was lower with CWS+DS compared with CWS (3.40 ± 0.52 and 4.51 ± 0.53, respectively; P = 0.003). Perceived leg fatigue was reduced with CTRL+DS compared with CTRL (2.36 ± 0.48 and 2.86 ± 0.59, respectively; P = 0.049) and lower with CWS+DS compared with CWS (1.86 ± 0.30 and 4.00 ± 0.79, respectively; P = 0.006). With unrestricted breathing, dead space did not change dyspnea at isoventilation, suggesting that dyspnea does not depend on the mode of reflex ventilatory stimulation in healthy individuals. With chest strapping, dead space presented a less potent stimulus to dyspnea, raising the possibility that leg muscle work contributes to dyspnea perception independent of the ventilatory stimulus. NEW & NOTEWORTHY Chest wall strapping was applied to healthy humans to simulate restrictive lung disease. With chest wall strapping, dyspnea was reduced when dead space substituted for part of a constant exercise stimulus to ventilation. Dyspnea associated with chest wall strapping depended on the contribution of leg muscle work to ventilatory stimulation. Chest wall strapping might not be a clinically relevant model to determine whether an alternative reflex ventilatory stimulus mimics the intensity of exertional dyspnea.
Erysipelothrix rhusiopathiae Bloodstream Infection: A 22-Year Experience at Mayo Clinic, Minnesota
Adeel, Naima, Lewis, Roshan J., Enzler, Mark J., Tosh, Pritish K. , Marcelin, Jasmine R , Tan, Eugene M.

Open Forum Infectious Diseases | February 3, 2017 | Volume: 3 | Issue: suppl_1 | Pages: No page available

10.1093/ofid/ofw172.801 Get It

The Utility of Screening for Coccidioidomycosis in Recipients of Anti-TNF-α Therapy.
Choi, Kristal, Mertz, Lester E., Heigh, Russell I., Yiannias, James A. , Blair, Janis E.

Open Forum Infectious Diseases | February 2, 2017 | Volume: 3 | Issue: suppl_1 | Pages: No page available

10.1093/ofid/ofw172.1277 Get It

1443Candida Bloodstream Infection in Left Ventricular Assist Device Recipients
Riaz, Talha , Nienaber, Juhsien JC, Walker, Randall C., Park, Soon J., Sohail, Muhammad Abdullah , Baddour, Larry M.

Open Forum Infectious Diseases | February 2, 2017 | Volume: 1 | Issue: suppl_1 | Pages: S380-S380

10.1093/ofid/ofu052.989 Get It

Stroke Caused by Extracranial Disease
Barrett, Kevin M. , Brott, Thomas G.

Circulation Research | February 2, 2017 | Volume: 120 | Issue: 3 | Pages: 496-501

10.1161/circresaha.117.310138 | PMID 28154099 Get It

Extracranial internal carotid artery atherosclerotic occlusive disease is a common ischemic stroke mechanism. Vascular risk factor control remains the cornerstone of stroke prevention in patients with both asymptomatic and symptomatic carotid occlusive diseases. Intensive medical therapy refers to the contemporary approach of antiplatelet therapy, blood pressure control, low-density lipoprotein reduction, and lifestyle modification to reduce stroke risk. Carotid revascularization with endarterectomy or angioplasty and stenting are established treatments for patients with symptomatic carotid stenosis ≥70%. Previously accepted ischemic stroke preventative strategies, such as carotid revascularization for asymptomatic carotid stenosis, require reassessment given advances in both medical therapy and surgical techniques. The purpose of this review is to describe contemporary approaches to the management of extracranial carotid atherosclerotic occlusive disease and the basis of these recommendations. Results from recently published clinical trials will be highlighted in addition to updated information from clinical trials addressing knowledge gaps in prevention of stroke caused by extracranial disease.
Outcomes of Physician‐Staffed Versus Non‐Physician‐Staffed Helicopter Transport for ST‐Elevation Myocardial Infarction
Gunnarsson, Sverrir I., Busch, Mary S., Larson, Brenda, Gharacholou, S. Michael , Raval, Amish N. , Mitchell, Joseph , Li, Zhanhai

Journal of the American Heart Association | February 2, 2017 | Volume: 6 | Issue: 2 | Pages: No page available

10.1161/jaha.116.004936 | PMID 28154162 Get It

Background The effect of physician‐staffed helicopter emergency medical service ( HEMS ) on ST ‐elevation myocardial infarction ( STEMI ) patient transfer is unknown. The purpose of this study was to evaluate the characteristics and outcomes of physician‐staffed HEMS (Physician‐ HEMS ) versus non‐physician‐staffed (Standard‐ HEMS ) in patients with STEMI . Methods and Results We studied 398 STEMI patients transferred by either Physician‐ HEMS (n=327) or Standard‐ HEMS (n=71) for primary or rescue percutaneous coronary intervention at 2 hospitals between 2006 and 2014. Data were collected from electronic medical records and each institution's contribution to the National Cardiovascular Data Registry. Baseline characteristics were similar between groups. Median electrocardiogram‐to‐balloon time was longer for the Standard‐ HEMS group than for the Physician‐ HEMS group (118 vs 107 minutes; P =0.002). The Standard‐ HEMS group was more likely than the Physician‐ HEMS group to receive nitroglycerin (37% vs 15%; P <0.001) and opioid analgesics (42.3% vs 21.7%; P <0.001) during transport. In‐hospital adverse outcomes, including cardiac arrest, cardiogenic shock, and serious arrhythmias, were more common in the Standard‐ HEMS group (25.4% vs 11.3%; P =0.002). After adjusting for age, sex, Killip class, and transport time, patients transferred by Standard‐ HEMS had increased risk of any serious in‐hospital adverse event (odds ratio=2.91; 95% CI =1.39–6.06; P =0.004). In‐hospital mortality was not statistically different between the 2 groups (9.9% in the Standard‐ HEMS group vs 4.9% in the Physician‐ HEMS group; P =0.104). Conclusions Patients with STEMI transported by Standard‐ HEMS had longer transport times, higher rates of nitroglycerin and opioid administration, and higher rates of adjusted in‐hospital events. Efforts to better understand optimal transport strategies in STEMI patients are needed.
Clinical Experience with Desferrioxamine in Dialysis Patients With Aluminium Toxicity
McCarthy, James T. , Milliner, Dawn S. , JOHNSON, WILLIAM J., JOHNSON, WILLIAM J.

QJM: An International Journal of Medicine | February 2, 2017 | Volume: 74 | Issue: 3 | Pages: 257-276

10.1093/oxfordjournals.qjmed.a068434 Get It

Abstract A desferrioxamine (DFO) infusion test, using a DFO dose of 36.9±11.2 mg/kg (mean ±SD), was performed in 50 consecutive dialysis patients undergoing diagnostic bone biopsy. In 30 patients whose bones stained positively for aluminium the serum aluminium level increased by an average of 373±250.4 ng/ml. The increase in 20 aluminium-negative patients was 231±179.2 ng/ml (p≪0.05). Aluminium-positive patients had lower levels of immunoreactive parathyroid hormone (336±442 μleq/ml) than aluminium-negative patients (1278±1400 μleq/ml; p≪0.05). A change in serum aluminium level of &gt; 200 ng/ml after the administration of DFO was 73 percent sensitive and 50 percent specific, and had a positive predictive value of 69 percent for detecting positive bone aluminium staining. The combination of a baseline immunoreactive parathyroid hormone level ≪200 leq/ml and a change in serum aluminium of &gt; 200 ng/ml after DFO was 90 percent specific and had a positive predictive value of 85 percent. In the second phase of our study, 28 dialysis patients with aluminium toxicity received longterm therapy (11.0±4.3 months) with DFO at an average starting dose of 41.7±17.1 mg/kg, administered once weekly. The four deaths which occurred during this treatment involved the only patients who had advanced dialysis dementia. Seven patients with less severe neurological symptoms responded favourably. Fractures decreased from 1.7 fractures/patient/year to 0.1 fracture/patient/year. Muscular strength and overall functional class were improved or stable in 25 patients; myalgias and arthralgias were also stable or improved in 19 patients. After 5–7 months of treatment, serum aluminium levels decreased from 401±262 ng/ml to 245±217 ng/ml (p≪0.01); erythrocyte mean corpuscular volume increased from 86.3±10.91 fl to 94.1±9.23 fl (p≪0.02); and serum calcium decreased from 10.4±0.94 mg/dl to 9.9±0.70 mg/dl (p≪0.02). Serum immunoreactive parathyroid hormone levels remained stable in 25 patients, but severe hyperparathyroidism developed rapidly in three patients. Eight patients with transfusional iron overload had no change in serum ferritin levels. Iron depletion developed in six patients, with a decrease in serum ferritin from 251±229.8μg/l to 45±29.3μg/l, and they required parenteral iron supplementation. Significant side-effects occurring during long-term
1799Next Generation Fecal Transplant for Recurrent C. difficile Infection with and without Antiobiotic Pre-Treatment: Lessons Learned from the PUNCH CD Phase 2 Safety Study
Mariani, P., Price, Connie, Orenstein, Robert , Harris, H. L., Sobcinski, Mary Kay

Open Forum Infectious Diseases | February 2, 2017 | Volume: 1 | Issue: suppl_1 | Pages: S62-S63

10.1093/ofid/ofu051.171 Get It